|
BioVentrix Expands Life-Extending Transcatheter Heart Failure Treatment to …
Business Wire (press release) SAN RAMON, Calif. & PRAGUE–(BUSINESS WIRE)–BioVentrix, a pioneer of technologies and procedures for less-invasive treatment of heart failure (HF), today announced that placement of its Revivent-TC™ Ventricular Enhancement System, via Less … |
Research and Markets: Global Congestive Heart Failure Pipeline Highlights – 2014 – Business Wire (press release)
Research and Markets: Global Congestive Heart Failure Pipeline Highlights – 2014Business Wire (press release)The latest report Congestive Heart Failure Pipeline Highlights – 2014, provides most up-to-date information on key pipeline molecules in the gl…
Organ donation the best gift of all – Ballarat Courier
|
Organ donation the best gift of all
Ballarat Courier Organ donation the best gift of all. By FIONA HENDERSON. Dec. 12, 2013, 11:30 p.m.. TWO years ago, Ballarat’s Graham Mitchell was looking forward to a family Christmas get-together. Jo Forteath, nurse donation specialist with Donate for Life, with … |
Roche, Prothena to develop new antibodies for Parkinson's disease treatment – Pharmaceutical Business Review
Economic Times |
Roche, Prothena to develop new antibodies for Parkinson’s disease treatment
Pharmaceutical Business Review Roche and Prothena have agreed to jointly develop and commercialize new antibodies that target alpha-synuclein, including PRX002, Prothena’s monoclonal antibody for the treatment of Parkinson’s disease (PD). Currently, PRX002 is in preclinical … Roche and Prothena to Devlop Antibodies for Parkinson’s DiseasePharmaceutical Processing Roche and Prothena Enter Into Worldwide Collaboration to Co-Develop and Co …4-traders (press release) Roche, Prothena in $600M Parkinson’s…PharmaLive (press release) (subscription) Genetic Engineering News all 32 news articles » |
Emergent announces positive results from phase 1b study of otlertuzumab in … – pharmabiz.com
Emergent announces positive results from phase 1b study of otlertuzumab in …pharmabiz.comEmergent BioSolutions Inc., a specialty pharmaceutical company, has reported preliminary results from a phase Ib single-arm, open-label study evaluating the safe…
MDA Refuses Blood Donation from Ethiopian MK – Arutz Sheva
MDA Refuses Blood Donation from Ethiopian MKArutz ShevaMDA Refuses Blood Donation from Ethiopian MK. According to Health Ministry regulations, MDA will not accept blood donations from British or Ethiopian donors due to concern for Mad Cow disease. MK N…
Research and Markets: Escalating Heart Failure Prevalence to Drive Global … – Business Wire (press release)
Research and Markets: Escalating Heart Failure Prevalence to Drive Global …Business Wire (press release)A global increase in Congestive Heart Failure (CHF) prevalence, combined with improved device adoption rates, will see the worldwide Cardiac Assis…
HIV may up risk of heart disease – Indian Express
Indian ExpressHIV may up risk of heart diseaseIndian ExpressPeople infected with the Human immunodeficiency virus (HIV) may be at an increased risk of heart disease, a new research has warned. It is well known that patients with HIV have a high inciden…
Two-drug combo of rituximab and pidilizumab could help treat cancer – India.Com Health
India.Com HealthTwo-drug combo of rituximab and pidilizumab could help treat cancerIndia.Com Healthdrugs One drug attacks tumor cells directly, the other treats the immune system by taking the brakes off T cell response, and together, they put half of …
Treasure Coast Christmas Events, updated Dec. 12 – TCPalm
|
Treasure Coast Christmas Events, updated Dec. 12
TCPalm Holidays at McKee: Vintage Wurlitzer band organ playing classic holiday music, model trains, holiday letter writing, visits with Santa, Mrs. Claus’ Serendipity Candy Shop, lights, decorations. 6-8 p.m. Dec. 21-23. … Bring unwrapped toy or monetary … |